May Mediterranean diet contribute to reduce risk of multiple sclerosis?

Cavalla, Paola; Vercellino, Marco

doi:10.1177/13524585231190342

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a case-control study, a fish/seafood intake one time per week or one time per month with consistent fish oil treatment was related with a 44% lower disease risk or clinically isolated syndrome (CIS) compared to an intake of fish/seafood lower than one time per month and no fish oil supplement use [44]. Currently, only a few studies have evaluated the possible beneficial effect of healthy dietary patterns such as the Mediterranean diet (MD) on the disease disability and symptom severity of individuals with MS-studies which have suffered from several controversial and inconclusive results [45][46][47][48][49][50][51].…”

Section: Introductionmentioning

confidence: 99%

Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study

Dakanalis,

Tryfonos,

Pavlidou

et al. 2024

JPM

View full text Add to dashboard Cite

Background: The Mediterranean diet (MD) is well-known as a diet which may exert a protective effect against neurodegenerative diseases, including multiple sclerosis (MS). To date, only a few clinical surveys have assessed the potential effects of the MD in patients with MS. The purpose of the present study is to evaluate the potential effects of MD compliance on disease disability, quality of life, physical activity, depressive symptomatology, and blood biochemical parameters related to nutritional status in MS patients, considering several socio-demographic, anthropometric, and lifestyle characteristics. Methods: This is a cross-sectional study conducted on 558 adults with MS aged 18–64 years. Relevant questionnaires were utilized to evaluate socio-demographic and anthropometric parameters, disease disability (Expanded Disability Status Scale, EDSS), multidimensional health-related quality (MS Quality of Life-54, MSQOL-54), physical activity levels (International Physical Activity Questionnaire, IPAQ), depression (Beck Depression Inventory II, BDI-II), and MD adherence (MedDietScore), while several blood biochemical parameters were retrieved from the patients’ medical records. Results: Enhanced MD compliance was independently associated with a decreased frequency of overweight/obesity, as well as abdominal obesity, in patients suffering from MS. Elevated MD compliance was also independently associated with a decreased incidence of advanced disease disability, a higher prevalence of elevated physical activity, an improved quality of life, and lower depressive symptoms, as well as higher levels of certain blood biochemical parameters, which are effective indicators of iron deficiency and malnutrition. Conclusions: The present study found that higher MD adherence may slow down disease disability, promoting a better quality of life and mental health in adults with MS. Future prospective surveys are required to obtain conclusive results.

show abstract

Section: Introductionmentioning

confidence: 99%

Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study

Dakanalis,

Tryfonos,

Pavlidou

et al. 2024

JPM

View full text Add to dashboard Cite

show abstract

The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review

Lin,

Wang,

Gao

2024

Front. Nutr.

View full text Add to dashboard Cite

Some studies have investigated the impact of intermittent fasting (IF) for patients with multiple sclerosis (MS). We aimed to conduct a comprehensive systematic review to analyze and summarize all clinical studies concerning the effects of IF on patients with MS. We conducted an exhaustive review of information available in the Embase, Cochrane, and PubMed databases up until 1 September 2023. All clinical research relating to the impacts of IF for patients with MS were included. In total, this systematic review encompassed 5 studies, which included four RCTs and one pilot study. Each study involved was assessed of high quality. The results from these studies demonstrate that IF protocols could potentially serve as an effective dietary strategy for managing symptoms and improving the quality of life in individuals afflicted with MS. In conclusion, IF might be a potential beneficial dietary intervention for MS. However, the number of trials in this field is relatively limited. The large-scale clinical trials to investigate the effects of IF for MS are urgently needed, which may be helpful to manage this intricate neuroimmune disorder.Systematic review registrationhttps://inplasy.com, identifier INPLASY2023100021.

show abstract

May Mediterranean diet contribute to reduce risk of multiple sclerosis?

Cited by 2 publications

References 11 publications

Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study

Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study

The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review

Contact Info

Product

Resources

About